Literature DB >> 1847158

Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia.

E Griffin1, L Håkansson, H Formgren, K Jörgensen, C Peterson, P Venge.   

Abstract

Blood eosinophil count, serum concentrations of eosinophil cationic protein (ECP), eosinophil protein X (EPX), myeloperoxidase (MPO), and peak expiratory flow (PEF) rate were studied in 23 patients with severe labile asthma characterized by eosinophilia at the start and end of a treatment period of 5 weeks. The mean blood eosinophil count was 808 x 10(6)/L at the start of the treatment period. Serum ECP and EPX were significantly raised compared with that of the references, whereas the mean serum MPO level was normal. The mean PEF was significantly and negatively correlated to both blood eosinophil count and serum ECP and EPX, but the predominant correlation was that between blood eosinophil count and PEF. At the end of the treatment period, PEF had increased and the blood eosinophil count and serum ECP and EPX were reduced when these values were compared with the values at the start of the treatment period. There was a significant and negative correlation of mean PEF to serum ECP but not to the blood eosinophil count. In individual subjects, the decreases in the blood eosinophil counts and serum EPX were significantly correlated to the individual increases of mean PEF. In conclusion, the present investigation indicates that in patients with asthma and pronounced eosinophilia, the lung function of the patients was principally related to the number of circulating eosinophils, whereas, when their eosinophilia was reduced to moderate levels, the patient's lung function was closer related to the activity of the eosinophils.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847158     DOI: 10.1016/0091-6749(91)90014-f

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

Review 1.  New Insights in Oxidant Biology in Asthma.

Authors:  Serpil C Erzurum
Journal:  Ann Am Thorac Soc       Date:  2016-03

2.  Evidence for eosinophil activation in bronchiectasis unrelated to cystic fibrosis and bronchopulmonary aspergillosis: discrepancy between blood eosinophil counts and serum eosinophil cationic protein levels.

Authors:  C Kroegel; M Schüler; M Förster; R Braun; P R Grahmann
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

3.  Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2.

Authors:  S R White; M E Strek; G V Kulp; S M Spaethe; R A Burch; S P Neeley; A R Leff
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

4.  Regulation of the interleukin-5 receptor alpha-subunit on peripheral blood eosinophils from healthy subjects.

Authors:  C Hellman; G Halldén; B Hylander; J Lundahl
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

5.  Levels of soluble IL-2 receptor in plasma from asthmatics. Correlations with blood eosinophilia, lung function, and corticosteroid therapy.

Authors:  P Lassalle; M Sergant; Y Delneste; P Gosset; B Wallaert; M Zandecki; A Capron; M Joseph; A B Tonnel
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

6.  Serum eosinophilic cationic protein may predict clinical course of wheezing in young children.

Authors:  J R Villa; G García; S Rueda; A Nogales
Journal:  Arch Dis Child       Date:  1998-05       Impact factor: 3.791

Review 7.  Cellular and immunological markers of allergic and intrinsic bronchial asthma.

Authors:  J C Virchow; C Kroegel; C Walker; H Matthys
Journal:  Lung       Date:  1994       Impact factor: 2.584

8.  Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group.

Authors:  H A Kerstjens; P L Brand; P M de Jong; G H Koëter; D S Postma
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

9.  In vivo neutralization of eosinophil-derived major basic protein inhibits antigen-induced bronchial hyperreactivity in sensitized guinea pigs.

Authors:  J Lefort; M A Nahori; C Ruffie; B B Vargaftig; M Pretolani
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

10.  Eotaxin in serum of patients with asthma or chronic obstructive pulmonary disease: relationship with eosinophil cationic protein and lung function.

Authors:  K Jahnz-Ró yk; T Plusa; J Mierzejewska
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.